Article Text

Download PDFPDF
Doubling the dose of inhaled corticosteroids during asthma deterioration did not improve asthma control

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • * See glossary.

  • For correspondence: Dr T W Harrison, Nottingham City Hospital, Nottingham, UK.

  • Sources of funding: NHS Executive. Active and placebo corticosteroid inhalers provided by AstraZeneca, GlaxoWellcome, 3M, and Baker Norton.